The protective PLCG2 variants delay Alzheimer’s disease onset age in APOE ε 4 carriers
Preprint
Abstract
INTRODUCTION: We investigated the impact of protective PLCG2 -P522R and PLCG2 -3’UTR variants, and the TREM2 -R62H risk variant on Alzheimer’s disease (AD) onset age in relation to APOE ε4 status. Plasma-based biomarkers of the different variants were also explored. METHODS: Kaplan-Meier and survival analyses were performed using FinnGen genotype and clinical endpoint data to assess the onset ages of AD, anxiety, and type 2 diabetes. Plasma biomarkers related to metabolism and inflammation were analyzed in 145 FINGER cohort participants. RESULTS: PLCG2 -P522R and PLCG2 -3’UTR variants delayed AD onset, including among APOE ε 4 carriers. PLCG2 -P522R carriers showed elevated plasma ghrelin levels. TREM2 -R62H variant associated with an earlier onset of AD in APOE ε 4 carriers. DISCUSSION: Protective PLCG2 variants may mitigate APOE ε 4-mediated risk of AD, which coincide with increased plasma levels of ghrelin. These findings highlight the further need to explore biomarkers and mechanisms associated with the protective variants in relation to APOE ε 4.Keywords
This publication has 56 references indexed in Scilit:
- Ghrelin Induces Ferroptosis Resistance and M2 Polarization of Microglia to Alleviate Neuroinflammation and Cognitive Impairment in Alzheimer’s DiseaseJournal of Neuroimmune Pharmacology, 2025
- Heterozygous expression of the Alzheimer’s disease-protective PLCγ2 P522R variant enhances Aβ clearance while preserving synapsesCellular and Molecular Life Sciences, 2022
- The role of ghrelin and leptin in feeding behavior: Genetic and molecular evidenceEndocrinología, Diabetes y Nutrición (English Ed.), 2021
- Severe Autoinflammatory Manifestations and Antibody Deficiency Due to Novel Hypermorphic PLCG2 MutationsJournal of Clinical Immunology, 2020
- A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevityActa Neuropathologica, 2019
- Correlates of ghrelin and visfatin in metabolic syndrome patients with and without prediabetesInternational Journal of Diabetes in Developing Countries, 2018
- A Unique Microglia Type Associated with Restricting Development of Alzheimer’s DiseaseCell, 2017
- TREM2 variants and risk of Alzheimer’s disease: a meta-analysisNeurological Sciences, 2015
- A Hypermorphic Missense Mutation in PLCG2 , Encoding Phospholipase Cγ2, Causes a Dominantly Inherited Autoinflammatory Disease with ImmunodeficiencyThe American Journal of Human Genetics, 2012
- Neuroprotective Effect of Ghrelin in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson’s Disease by Blocking Microglial ActivationNeurotoxicity Research, 2009